Carbamazepine Treatment for Cocaine Dependence - 5

University of Pennsylvania

Status and phase: Completed; Phase 2

Conditions: Cocaine-Related Disorders

Treatments: Drug: Carbamazepine

Study type: Interventional

Funder types: Other; NIH

Identifiers

NCT00000191

NIDA-00144-5

3R01DA012268 (U.S. NIH Grant/Contract)

K20-00144-5

Details and patient eligibility

About

The purpose of this study is to assess carbamazepine as a pharmacotherapy for cocaine dependence.

Sex: All

Ages: 21 to 51 years old

Volunteers: No Healthy Volunteers

Inclusion and exclusion criteria

Please contact site for information.